Texas Instruments Incorporated
284.69USD
+5.1900 (+1.86%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TXN.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.62▲ | $2.28 | 24 | 0 |
| Next quarter | $2.62▲ | $2.26 | 21 | 0 |
| Current year | $9.06▲ | $8.5 | 25 | 0 |
| Next year | $11.55▲ | $10.03 | 23 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-09-30 | $2.43 | $2.62 | +0.19 (+7.9%) |
| 2026-06-30 | $1.94 | $2.14 | +0.20 (+10.5%) |
| 2026-03-31 | $1.37 | $1.68 | +0.31 (+22.8%) |
| 2025-12-31 | $1.31 | $1.27 | -0.04 (-2.9%) |
663 ratings from 58 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Jefferies | Maintained | Hold | $260 $300 | Oct 22, 2026 |
| Freedom Broker | Upgraded from Hold | Buy | $260 $330 | Oct 22, 2026 |
| UBS | Maintained | Buy | $380 $360 | Oct 22, 2026 |
| Morgan Stanley | Maintained | Underweight | $255 $278 | Oct 22, 2026 |
| Barclays | Maintained | Equal-Weight | $250 $280 | Oct 22, 2026 |
| JP Morgan | Maintained | Overweight | $340 $365 | Oct 22, 2026 |
| Stifel | Maintained | Buy | $360 $370 | Oct 22, 2026 |
| Rosenblatt | Maintained | Buy | $350 $360 | Oct 22, 2026 |
| Mizuho | Maintained | Neutral | $305 $290 | Oct 22, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $310 $300 | Oct 20, 2026 |
| TD Cowen | Maintained | Buy | $340 $330 | Oct 19, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $340 | Aug 17, 2026 |
| Rosenblatt | Maintained | Buy | $330 $350 | Jul 24, 2026 |
| Bernstein | Maintained | Market Perform | $250 $290 | Jul 23, 2026 |
| JP Morgan | Maintained | Overweight | $280 $340 | Jul 23, 2026 |
| Morgan Stanley | Maintained | Underweight | $230 $255 | Jul 23, 2026 |
| TD Cowen | Maintained | Buy | $360 $340 | Jul 23, 2026 |
| Truist Securities | Maintained | Hold | $278 $300 | Jul 23, 2026 |
| Mizuho | Maintained | Neutral | $300 $305 | Jul 23, 2026 |
| Baird | Maintained | Outperform | $300 $385 | Jul 23, 2026 |
| Goldman Sachs | Maintained | Sell | $200 $225 | Jul 23, 2026 |
| Benchmark | Maintained | Buy | $315 $360 | Jul 23, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $300 $310 | Jul 23, 2026 |
| Evercore ISI Group | Maintained | Outperform | $316 $330 | Jul 23, 2026 |
| Keybanc | Maintained | Overweight | $390 $400 | Jul 23, 2026 |
156 filings from 26 insiders · 20 buy / 20 sell over 6m
Officers and directors of TXN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| FARMER CURTIS CDirector | GrantStock Units | 106.53 | $258.14 | $27k | Sep 18, 2026 |
| PATSLEY PAMELA HDirector | GrantStock Units | 106.53 | $258.14 | $27k | Sep 18, 2026 |
| Abraham TsedeniyaOfficer, Sr. Vice President | ExerciseNQ Stock Option (Right to Buy) | 1.4k | — | — | Aug 27, 2026 |
| Abraham TsedeniyaOfficer, Sr. Vice President | Sell | 592 | $264.96 | $157k | Aug 27, 2026 |
| Abraham TsedeniyaOfficer, Sr. Vice President | Sell | 6.4k | $264.60 | $1.70M | Aug 27, 2026 |
| Abraham TsedeniyaOfficer, Sr. Vice President | Exercise | 1.4k | $79.26 | $108k | Aug 27, 2026 |
| KNECHT JULIE C.Officer | Grant | 7.2k | — | — | Jul 24, 2026 |
| CRAIGHEAD MARTIN SDirector | Sell | 10.0k | $320.41 | $3.20M | May 28, 2026 |
| LIZARDI RAFAEL RChief Financial Officer | Exercise | 47.7k | $174.81 | $8.34M | May 14, 2026 |
| BAHAI AHMADOfficer | Exercise | 5.0k | $110.15 | $551k | May 14, 2026 |
| BAHAI AHMADOfficer | Sell | 5.0k | $309.13 | $1.55M | May 14, 2026 |
| LIZARDI RAFAEL RChief Financial Officer | Sell | 47.7k | $307.85 | $14.71M | May 14, 2026 |
| COX CARRIE SMITHDirector | Exercise | 8.8k | $104.41 | $947k | May 13, 2026 |
| COX CARRIE SMITHDirector | Sell | 8.8k | $306.37 | $2.71M | May 13, 2026 |
| LEONARD SHANON JOfficer | Sell | 5.0k | $295.22 | $1.47M | May 11, 2026 |
| ILAN HAVIVChief Executive Officer | Exercise | 20.0k | $79.26 | $1.59M | May 4, 2026 |
| ILAN HAVIVChief Executive Officer | Sell | 20.0k | $280.32 | $5.61M | May 4, 2026 |
| KNECHT JULIE C.Officer | Exercise | 5.4k | $130.52 | $702k | May 1, 2026 |
| KNECHT JULIE C.Officer | Sell | 10.0k | $278.69 | $2.77M | May 1, 2026 |
| GARY MARKOfficer | Exercise | 13.7k | $130.52 | $1.79M | Apr 30, 2026 |
No analyst notes on TXN yet.
Analyst Ratings
29 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 18 | 13 | 2 | 0 | Buy2.43 |
| 1 mo ago | 3 | 17 | 14 | 2 | 0 | Buy2.42 |
| 2 mo ago | 3 | 17 | 14 | 2 | 0 | Buy2.42 |
| 3 mo ago | 2 | 16 | 16 | 2 | 0 | Hold2.50 |
Members whose judged calls on TXN have played out most reliably.
No settled calls on TXN yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice